Figure 3From: Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature Clinical course as assessed by tumor markers and therapeutic events from discovery of hepatocellular carcinoma to present. HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization; RFA, radiofrequency ablation; HAIC, hepatic arterial infusion chemotherapy; AFP, alpha-fetoprotein.Back to article page